Crescent Grove Advisors’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-60,000
| Closed | -$21.6K | – | 310 |
|
|
2023
Q1 | $21.6K | Buy |
60,000
+38,000
| +173% | +$13.7K | ﹤0.01% | 279 |
|
|
2022
Q4 | $19.5K | Buy |
22,000
+1,000
| +5% | +$886 | ﹤0.01% | 273 |
|
|
2022
Q3 | $33K | Buy |
21,000
+1,000
| +5% | +$1.57K | ﹤0.01% | 257 |
|
|
2022
Q2 | $40K | Hold |
20,000
| – | – | ﹤0.01% | 257 |
|
|
2022
Q1 | $47K | Sell |
20,000
-23,000
| -53% | -$54.1K | ﹤0.01% | 291 |
|
|
2021
Q4 | $200K | Buy |
43,000
+21,000
| +95% | +$97.7K | 0.02% | 284 |
|
|
2021
Q3 | $168K | Buy |
22,000
+2,000
| +10% | +$15.3K | 0.02% | 257 |
|
|
2021
Q2 | $194K | Buy |
+20,000
| New | +$194K | 0.02% | 255 |
|